-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613.O1.6 613. Acute Myeloid Leukemia: Clinical and Epidemiological: COVID and beyond

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, Adults, Epidemiology, Clinical Research, Elderly, Clinically Relevant, Diseases, Real World Evidence, Adverse Events, Myeloid Malignancies, Young Adults, Study Population, Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value; etc.)
Saturday, December 11, 2021: 2:00 PM-3:30 PM
B308-B309, Level 3, Building B (Georgia World Congress Center)
Moderators:
Jessica K. Altman, MD, Northwestern University Feinberg School of Medicine and Tapan M. Kadia, MD, M.D. Anderson Cancer Center
Disclosures:
Altman: BMS: Research Funding; AbbVie: Consultancy, Other: Advisory Board, Research Funding; Syros: Consultancy; BlueBird: Consultancy; Theradex: Consultancy, Other: Advisory board; ALX Oncology: Research Funding; Kartos: Research Funding; Immunogen: Research Funding; Kura: Research Funding; Aprea: Research Funding; GlycoMimetics: Other: Data Monitoring Committee ; Kura Oncology: Consultancy; Fujifilm: Research Funding; Biosight: Consultancy, Other: Travel fees, Research Funding; Daiichi Sankyo: Consultancy; Amgen: Research Funding; Boehringer Ingelheim: Research Funding; Astellas: Consultancy, Other: Advisory Board, Research Funding. Kadia: AbbVie: Consultancy, Other: Grant/research support; Agios: Consultancy; Amgen: Other: Grant/research support; BMS: Other: Grant/research support; Cure: Speakers Bureau; Dalichi Sankyo: Consultancy; Genentech: Consultancy, Other: Grant/research support; Jazz: Consultancy; Liberum: Consultancy; Novartis: Consultancy; Pfizer: Consultancy, Other; Pulmotech: Other; Sanofi-Aventis: Consultancy; Cellonkos: Other; Ascentage: Other; Genfleet: Other; Astellas: Other; AstraZeneca: Other.
2:00 PM

Akriti G Jain, MD1, Ning C. Dong, MD1, Somedeb Ball, MD1, Elaine S Tan, MD1, Junmin Whiting2*, Rami S. Komrokji, MD1, Kendra Sweet, MD1, Onyee Chan, MD3, David A. Sallman, MD4, Eric Padron, MD1, Andrew T. Kuykendall, MD1, Anna Giuliano5* and Jeffrey E. Lancet, MD6

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Statistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
5Center for Immunization and Infection Research in Cancer (CIIRC), H. Lee Moffitt Cancer Center, Tampa
6Department of Malignant Hematology, H. Lee Moffitt Cancer Ctr. & Rsrch. Institute, Tampa, FL

2:15 PM

Jil Rotterdam, jil.rotterdam@medma.uni-heidelberg.de1*, Margot Thiaucourt, Dr. med.2*, Juliana Schwaab1*, Andreas Reiter, MD1*, Sebastian Kreil1*, Laurenz Steiner, MD PhD1*, Henning D. Popp1*, Wolf-Karsten Hofmann, MD PhD1, Karin Bonatz1*, Catharina Gerhards2*, Michael Neumaier2*, Mohamad Jawhar, MD PhD1* and Susanne Saussele, MD 1

1III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
2Institut für Klinische Chemie, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany

2:30 PM

Isla McKerrow Johnson1*, Evandro D. Bezerra, MD2, Faiqa Farrukh, MBBS3*, Kristen McCullough, PharmD4*, Aref Al-Kali, MD2, Hassan B. Alkhateeb, MD2*, Kebede H. Begna, MD5, Mark R. Litzow, MD2, William J Hogan, MB, BCh2, Mithun V. Shah, MD, PhD6, Mrinal M. Patnaik, MD, MBBS2, Ayalew Tefferi, MD2 and Naseema Gangat, MBBS2

1Department of Medicine, Mayo Clinic, Rochester
2Division of Hematology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester
4Division of Pharmacology, Mayo Clinic, Rochester, MN
5Divison of Hematology, Mayo Clinic, Rochester, MN
6Mayo Clinic, Rochester, MN

2:45 PM

Xu Wang, Phd1*, Ian Thomas2*, Cono Ariti, MSc3*, Mike Dennis, MD, MRCP, FRCPath4, Priyanka Mehta, MD5*, Nigel H Russel6*, Mia Sydenham7*, Robert Hills, PhD8*, Alan K. Burnett, MD9, Sucha Nand, MD10, Sarit Assouline, MD11, Laura C. Michaelis, MD12, Harry P. Erba, MD, PhD13, Kathleen Kerr, PhD1*, Roland B. Walter, MD14 and Megan Othus, PhD15

1University of Washington, Seattle, WA
2Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
3Cardiff University, Cardiff, WAL, GBR
4Christie Hospital, Manchester, United Kingdom
5The University of Bristol, Bristol, United Kingdom
6Nottingham University, Nottingham, United Kingdom
7Cardiff University, Cardiff, United Kingdom
8Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
9Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, United Kingdom
10Loyola University Medical Center, Maywood, IL
11Segal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal, Canada
12Division of Hematology/Oncology, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
13Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC
14Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
15Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA

3:00 PM

Karilyn Larkin, MD1, Deedra Nicolet2,3*, Ben Kelly, M.S.4*, Krzysztof Mrózek, MD, PhD5,6, Katherine E Miller, PhD7*, Saranga Wijeratne, M.S.8*, Stephanie LaHaye, PhD8*, Jessica Kohlschmidt, PhD6,9,10, James S. Blachly, MD11, Alice S. Mims, MD12, Christopher J. Walker, PhD1, Christopher C. Oakes, PhD1, Shelley Orwick, B.S.12*, Isaiah Boateng2*, Jill Buss, B.S.13*, Adrienne Heyrosa14*, Andrew J Carroll, PhD15, William Blum, MD16, Bayard L. Powell, MD17, Jonathan E Kolitz, MD18, Joseph O. Moore, MD19, Robert James Mayer, MD20, Richard A. Larson, MD21, Richard M. Stone, MD22, Electra D. Paskett, PhD23*, John C. Byrd, MD24, Elaine R. Mardis, PhD7* and Ann-Kathrin Eisfeld, MD25,26

1The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
3Alliance Statistics and Data Center, The Ohio State University, Columbus, OH
4Nationwide Children's Hospital and Ohio State University College of Medine, Columbus, OH
5The Ohio State University, Comprehensive Cancer Center, Columbus, OH
6The Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
7The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH
8The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH
9The Clara D. Bloomfield Center for Leukemia Outcomes Research, 4The Ohio State University Comprehensive Cancer Center, Hilliard, OH
10Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH
11Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
12Division of Hematology, The Ohio State University, Columbus, OH
13The Ohio State University, Columbus, OH
141Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
15Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
16Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
17Wake Forest Baptist Health Comprehensive Cancer Center, Winston-Salem, NC
18Northwell Health Cancer Institute, Department of Medicine, Division of Hematology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
19Duke University Medical Center, Durham, NC
20Dana-Farber Cancer Inst., Boston, MA
21Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL
22Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
23Division of Cancer Prevention and Control, The Ohio State University, Columbus, OH
24College of Medicine, University of Cincinnati, Cincinnati, OH
25Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
26The Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH

3:15 PM

Gi June Min, M.D., Ph.D.1, Byung Sik Cho, M.D., Ph.D.1*, Sung-Soo Park, M.D., Ph.D.1*, Silvia Park, M.D., Ph.D.2*, Young-Woo Jeon, M.D., Ph.D.3*, Seung-Hwan Shin, M.D., Ph.D.4*, Seung-Ah Yahng, M.D., Ph.D.5*, Jae-Ho Yoon, MD2, Sung-Eun Lee, M.D., Ph.D.1*, Ki-Seong Eom, M.D., Ph.D.6*, Yoo-Jin Kim, M.D., Ph.D.2, Seok Lee, M.D., Ph.D.2, Chang-Ki Min, M.D., Ph.D.2*, Seok-Goo Cho, M.D., Ph.D.1*, Dong-Wook Kim, M.D., Ph.D.7, Jong Wook Lee, M.D., Ph.D.1 and Hee-Je Kim, M.D., Ph.D.8

1Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Yeouido St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Department of Hematology, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
5Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, Republic of (South)
6Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7Department of Hematology, The Catholic University of Korea, Seoul, Korea, Republic of (South)
8Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

*signifies non-member of ASH